FDA-Inspected Site

Galephar Pharmaceutical Research Inc

9 FDA inspections are on record for Galephar Pharmaceutical Research Inc in Juncos, United States.

483· Form 483 issued

Juncos, United States · Last updated July 10, 2026

Overview

  • 9 FDA inspections are on record.
  • 6 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-10-18.

At a glance

Inspections

9

Form 483s

6

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
15 Oct 2024 – 18 Oct 2024Human Drugs483View 483 →
1 Jun 2021 – 9 Jun 2021Human Drugs483On file
9 Oct 2018 – 24 Oct 2018Human Drugs483On file
17 Nov 2015 – 23 Nov 2015Human Drugs483View 483 →
29 Sep 2011Not recorded483View 483 →
4 Jun 2010Not recordedClean
30 Jan 2009Not recorded483On file
12 Nov 2008Not recordedClean
8 May 2007Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

18 Oct 2024
21 CFR 211.188(b)(12)

Investigations made into any unexplained discrepancy

Cited by Marian E Ramirez, Christian F Gomez Lugo

23 Nov 2015
21 CFR 211.198(a)

Complaint Handling Procedure

Cited by Vilmary Negron Rodriguez, Ramon A Hernandez

29 Sep 2011
21 CFR 211.22(a)

Approve or reject components, products

Cited by Rebecca Parrilla

Investigators

FDA investigators tied to this site in the record.

Ariel Cruz Figueroa1 insp.
Vilmary Negron Rodriguez1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.188(b)(12)Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Galephar Pharmaceutical Research Inc's 6 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat